Fountain Therapeutics

About:

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.

Website: http://fountaintx.com/

Top Investors: Khosla Ventures, Alexandria Venture Investments, Eli Lilly & Company Foundation, R42 Group, Nan Fung Life Sciences

Description:

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases. Fountain Therapeutics was founded with the belief that a future in which we live healthier lives longer is more desirable than one in which the company continues to be afflicted by the disease of aging. The company builds a transformative model of aging that re-creates many of the complex hallmark features of aging but in a laboratory dish. We are combining this powerful cellular model with the latest in artificial intelligence and computer vision to develop a disruptive unbiased platform for the identification of novel targets and potential therapeutics.

Total Funding Amount:

$26M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Founders:

Joseph Rodgers, Thomas Rando, Tom Cheung

Number of Employees:

11-50

Last Funding Date:

2021-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai